Subscribe to Money Morning get daily headlines subscribe now! Money Morning Private Briefing today's private briefing Access Your Profit Alerts

Nexvet Biopharma Ord (NASDAQ: NVET)

$6.64 USD $0.01 (0.15%)
Last Price $6.64
Net Change $0.01 (0.15%)
Bid $0
Ask Price $0
Open Price $6.64
Previous Close Price $6.63
High Price $6.65
Low Price $6.64
Number of Trades 34
Volume 15,100
Fifty Two Week High $6.76 (2017-04-13)
Fifty Two Week Low $2.75 (2017-02-13)
Average Daily Volume 48,266
Share Outstanding 11,920 Shares
Total Dividend Payout 0/yr
Dividend Yield 0%
1st Quarter Earnings $ ()
2nd Quarter Earnings $ ()
3nd Quarter Earnings $ ()
4th Quarter Earnings $ ()
PE Ratio $0
EPS Growth $-4.17
Recent Earnings $
Annual EPS $-1.75
Last Quarter EPS $
Market Capitalization $0.08B
Insider Shareholders % 0.37%
Annual Revenue $0B
No. Shares Outstanding 11,920
Inst. Shareholder % 48.4%
Annual Net Income $-0.02B
TTM Net Profit Margin $0
1-Year Return 110.13%
3-Year Return -25.23%
5-Year Return -25.23%
5-Year Revenue Growth 0%
5-Year Earnings Growth 0%
5-Year Dividend Growth 0%
Annual Dividend $0
Annual Dividend Yield 0%
Change in EPS YTD -4.17%
Dividends per Share $
Stock Split Ratio
Beta 0.64
NexvetBiopharma plc is a biopharmaceutical company. The company is focused on transforming the therapeutic market for companion animals by developing and commercializing novel biologic therapies. Its product candidate consists of NV-01, is a mAb for the control of pain associated with osteoarthritis in dogs, NV-02, is a mAb for the control of pain associated with degenerative joint disease in cats and NV-08, is a receptor fusion protein for the treatment of chronic inflammatory diseases. NexvetBiopharma plc is headquartered in Blackrock, Ireland.

NVET News & Stock Updates